HM
QGENF

HealthCor Management’s QIAGEN NV QGENF Stock Holding History

HealthCor Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,850,000
Closed -$79.9M – 51
2016
Q4 		$79.9M Buy
2,850,000
+575,000
+25% +$16.1M 4.51% 6
2016
Q3 		$62.4M Sell
2,275,000
-225,000
-9% -$6.17M 3.8% 11
2016
Q2 		$54.5M Buy
+2,500,000
New +$54.5M 2.97% 12

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.7B AUM 32.92% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return

HealthCor Management's QGENF Position: Q1 2017 in Review

HealthCor Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 2,850,000 shares — an estimated $79.9M sold.

HealthCor Management first reported a position in QGENF in Q2 2016 and held it in 3 quarters. The position peaked at $79.9M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • HealthCor Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • HealthCor Management sold 2,850,000 QIAGEN NV shares in Q1 2017, an estimated $79.9M.
  • HealthCor Management first reported a position in QIAGEN NV in Q2 2016 and held it in 3 quarters.
  • HealthCor Management's QIAGEN NV position peaked at $79.9M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on HealthCor Management's 13F filing for Q1 2017, filed 15 May 2017.